Analysts expect Adicet Bio, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 131.67 M | 157.93 M | 135.42 M | 128.02 M | 125.55 M | 190.13 M | 194.62 M | 185.26 M | 171.23 M | 186.00 M | 168.88 M | 164.41 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 150.16 M | 153.41 M | 160.27 M | 138.02 M | 134.67 M | 166.89 M | 190.94 M | 211.03 M | 170.08 M | 196.08 M | 209.48 M | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.60 M | 3.12 M | 15.63 M | 24.52 M | ||||||||||
| Low Estimate | 131.78 M | 144.44 M | 134.68 M | 117.34 M | 120.41 M | 151.56 M | 168.74 M | 190.52 M | 151.12 M | 169.05 M | 183.78 M | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 M | 2.78 M | 14.15 M | 21.05 M | ||||||||||
| Consensus Estimate | 140.97 M | 148.93 M | 147.48 M | 127.68 M | 127.54 M | 159.22 M | 179.84 M | 200.77 M | 160.60 M | 182.56 M | 196.63 M | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.30 M | 2.95 M | 14.89 M | 22.79 M |
Analysts expect Adicet Bio, Inc. to report earnings per share of -1.52 for Q3 26, against a range of -1.63 to -1.41. The most recent reported quarter, Q2 26, came in at -1.99, a 24.4% miss against the -1.60 consensus.
| Metric | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.36 | 0.42 | 0.35 | 0.28 | 0.24 | 0.39 | 0.27 | 0.30 | 0.22 | 0.01 | -0.48 | -0.59 | -5.44 | -5.12 | -4.96 | -5.44 | -4.64 | -2.94 | -1.88 | -1.99 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 0.41 | 0.37 | 0.30 | 0.31 | 0.42 | 0.53 | 0.31 | 0.24 | 0.28 | 0.28 | - | -5.33 | -5.49 | -5.22 | -4.96 | -4.23 | -2.59 | -2.72 | -1.52 | -1.41 | -1.35 | -1.62 | -1.68 | -0.99 | -0.54 | -0.47 | -0.59 | ||||||||||
| Low Estimate | - | 0.37 | 0.35 | 0.26 | 0.27 | 0.38 | 0.45 | 0.27 | 0.20 | 0.24 | 0.26 | - | -5.85 | -6.27 | -5.88 | -5.40 | -4.61 | -2.83 | -3.10 | -1.68 | -1.63 | -1.51 | -1.90 | -1.82 | -1.13 | -0.64 | -0.55 | -0.73 | ||||||||||
| Consensus Estimate | - | 0.39 | 0.36 | 0.28 | 0.29 | 0.40 | 0.49 | 0.29 | 0.22 | 0.26 | 0.27 | - | -5.59 | -5.88 | -5.55 | -5.18 | -4.42 | -2.71 | -2.91 | -1.60 | -1.52 | -1.43 | -1.76 | -1.75 | -1.06 | -0.59 | -0.51 | -0.66 |
Pull Wall Street consensus for Adicet Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ACET&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ACET", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ACET&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();